PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.86%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.47%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-39.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-41.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-41.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
3.54%
Share change of 3.54% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.54%
Diluted share change of 3.54% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-15.66%
Negative OCF growth while UPM.HE is at 36.25%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.73%
Negative FCF growth while UPM.HE is at 50.64%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.54%
Negative 10Y revenue/share CAGR while UPM.HE stands at 37.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-7.94%
Negative 5Y CAGR while UPM.HE stands at 6.44%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.17%
3Y revenue/share CAGR above 1.5x UPM.HE's 6.58%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
240.15%
10Y OCF/share CAGR above 1.5x UPM.HE's 38.92%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-68.02%
Negative 5Y OCF/share CAGR while UPM.HE is at 102.26%. Joel Greenblatt would question the firm’s operational model or cost structure.
247.30%
3Y OCF/share CAGR above 1.5x UPM.HE's 0.49%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
134.89%
Below 50% of UPM.HE's 3085.82%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
105.96%
5Y net income/share CAGR 1.25-1.5x UPM.HE's 89.43%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
66.67%
3Y net income/share CAGR above 1.5x UPM.HE's 24.41%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
46.50%
5Y equity/share CAGR above 1.5x UPM.HE's 30.13%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.39%
3Y equity/share CAGR 1.25-1.5x UPM.HE's 24.76%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
233.14%
5Y dividend/share CAGR above 1.5x UPM.HE's 116.67%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
81.82%
3Y dividend/share CAGR 1.25-1.5x UPM.HE's 73.31%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-3.07%
Firm’s AR is declining while UPM.HE shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.73%
We show growth while UPM.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.96%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.70%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
18.05%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
9.57%
SG&A growth of 9.57% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.